Search

J. R. Mcdowell

Examiner (ID: 446)

Most Active Art Unit
2612
Art Unit(s)
2612, 2628, 2677, 2678
Total Applications
1124
Issued Applications
974
Pending Applications
48
Abandoned Applications
123

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8096265 [patent_doc_number] => 20120083747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-05 [patent_title] => 'Vaginal renewal complex and applicator' [patent_app_type] => utility [patent_app_number] => 13/200851 [patent_app_country] => US [patent_app_date] => 2011-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 952 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20120083747.pdf [firstpage_image] =>[orig_patent_app_number] => 13200851 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/200851
Vaginal renewal complex and applicator Oct 2, 2011 Abandoned
Array ( [id] => 7490565 [patent_doc_number] => 20110237618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'METHODS FOR TREATING MIGRAINES WITH HUPERZINE A DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 13/154398 [patent_app_country] => US [patent_app_date] => 2011-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5126 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237618.pdf [firstpage_image] =>[orig_patent_app_number] => 13154398 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/154398
METHODS FOR TREATING MIGRAINES WITH HUPERZINE A DERIVATIVES Jun 5, 2011 Abandoned
12/991353 MODULATORS OF MCAM IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA Feb 23, 2011 Abandoned
Array ( [id] => 7587326 [patent_doc_number] => 20110281836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'Silent desensitizers of neuronal NACHR and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/927688 [patent_app_country] => US [patent_app_date] => 2010-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16991 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 51 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281836.pdf [firstpage_image] =>[orig_patent_app_number] => 12927688 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/927688
Silent desensitizers of neuronal NACHR and methods of use thereof Nov 18, 2010 Abandoned
Array ( [id] => 5944939 [patent_doc_number] => 20110105559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'Compositions and Methods for Treating, Controlling, Reducing, Ameliorating, or Preventing Allergy' [patent_app_type] => utility [patent_app_number] => 12/909387 [patent_app_country] => US [patent_app_date] => 2010-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 50233 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105559.pdf [firstpage_image] =>[orig_patent_app_number] => 12909387 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/909387
Compositions and Methods for Treating, Controlling, Reducing, Ameliorating, or Preventing Allergy Oct 20, 2010 Abandoned
Array ( [id] => 7656514 [patent_doc_number] => 20110305783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'Method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma and/or parakeratosis by inhibiting expression of squamous cell carcinoma-related antigen' [patent_app_type] => utility [patent_app_number] => 12/907412 [patent_app_country] => US [patent_app_date] => 2010-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14748 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20110305783.pdf [firstpage_image] =>[orig_patent_app_number] => 12907412 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/907412
Method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma and/or parakeratosis by inhibiting expression of squamous cell carcinoma-related antigen Oct 18, 2010 Abandoned
Array ( [id] => 8244958 [patent_doc_number] => 08202886 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-19 [patent_title] => 'Small molecule E2F inhibitor' [patent_app_type] => utility [patent_app_number] => 12/872263 [patent_app_country] => US [patent_app_date] => 2010-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 28 [patent_no_of_words] => 9630 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/202/08202886.pdf [firstpage_image] =>[orig_patent_app_number] => 12872263 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/872263
Small molecule E2F inhibitor Aug 30, 2010 Issued
Array ( [id] => 5943648 [patent_doc_number] => 20110104268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'GALENIC APPLICATIONS OF SELF-EMULSIFYING MIXTURES OF LIPIDIC EXCIPIENTS' [patent_app_type] => utility [patent_app_number] => 12/870250 [patent_app_country] => US [patent_app_date] => 2010-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8073 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104268.pdf [firstpage_image] =>[orig_patent_app_number] => 12870250 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/870250
GALENIC APPLICATIONS OF SELF-EMULSIFYING MIXTURES OF LIPIDIC EXCIPIENTS Aug 26, 2010 Abandoned
Array ( [id] => 6645330 [patent_doc_number] => 20100227922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'Long-term stable pharmaceutical preparation containing the active ingredient glyceryl trinitrate' [patent_app_type] => utility [patent_app_number] => 12/789217 [patent_app_country] => US [patent_app_date] => 2010-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3577 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20100227922.pdf [firstpage_image] =>[orig_patent_app_number] => 12789217 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/789217
Long-term stable pharmaceutical preparation containing the active ingredient glyceryl trinitrate May 26, 2010 Issued
Array ( [id] => 6267841 [patent_doc_number] => 20100298430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'PROPHYLACTIC ANTISTRESS AGENT' [patent_app_type] => utility [patent_app_number] => 12/786910 [patent_app_country] => US [patent_app_date] => 2010-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2434 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298430.pdf [firstpage_image] =>[orig_patent_app_number] => 12786910 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/786910
PROPHYLACTIC ANTISTRESS AGENT May 24, 2010 Abandoned
Array ( [id] => 7683701 [patent_doc_number] => 20100240710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'Use of Pyridoxamine to Treat and/or Prevent Disease Processes' [patent_app_type] => utility [patent_app_number] => 12/775641 [patent_app_country] => US [patent_app_date] => 2010-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12948 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20100240710.pdf [firstpage_image] =>[orig_patent_app_number] => 12775641 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/775641
Use of Pyridoxamine to Treat and/or Prevent Disease Processes May 6, 2010 Abandoned
Array ( [id] => 6276332 [patent_doc_number] => 20100256214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'EPH RECEPTOR LIGANDS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/751203 [patent_app_country] => US [patent_app_date] => 2010-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 35188 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20100256214.pdf [firstpage_image] =>[orig_patent_app_number] => 12751203 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/751203
EPH RECEPTOR LIGANDS AND METHODS OF USE Mar 30, 2010 Abandoned
Array ( [id] => 6517477 [patent_doc_number] => 20100216893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'Long-term stable pharmaceutical preparation containing the active ingredient glycerol trinitrate' [patent_app_type] => utility [patent_app_number] => 12/752070 [patent_app_country] => US [patent_app_date] => 2010-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3546 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216893.pdf [firstpage_image] =>[orig_patent_app_number] => 12752070 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/752070
Long-term stable pharmaceutical preparation containing the active ingredient glycerol trinitrate Mar 30, 2010 Abandoned
Array ( [id] => 6637358 [patent_doc_number] => 20100173856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'METHODS OF PRODUCING AND USING NUTRITIONAL AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE ONE OR MORE ACTIVE SUBSTANCES' [patent_app_type] => utility [patent_app_number] => 12/728992 [patent_app_country] => US [patent_app_date] => 2010-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3781 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173856.pdf [firstpage_image] =>[orig_patent_app_number] => 12728992 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/728992
METHODS OF PRODUCING AND USING NUTRITIONAL AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE ONE OR MORE ACTIVE SUBSTANCES Mar 21, 2010 Abandoned
Array ( [id] => 7703021 [patent_doc_number] => 08088775 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-03 [patent_title] => 'Pharmaceutical composition for treating hair loss' [patent_app_type] => utility [patent_app_number] => 12/722720 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 6795 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/088/08088775.pdf [firstpage_image] =>[orig_patent_app_number] => 12722720 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/722720
Pharmaceutical composition for treating hair loss Mar 11, 2010 Issued
Array ( [id] => 6195604 [patent_doc_number] => 20110027359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'Novel Pharmaceutical Compositions Comprising Levetiracetam' [patent_app_type] => utility [patent_app_number] => 12/720768 [patent_app_country] => US [patent_app_date] => 2010-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5612 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20110027359.pdf [firstpage_image] =>[orig_patent_app_number] => 12720768 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/720768
Novel Pharmaceutical Compositions Comprising Levetiracetam Mar 9, 2010 Abandoned
Array ( [id] => 8305979 [patent_doc_number] => 08227514 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-24 [patent_title] => 'Topical application of travoprost for combating hair loss' [patent_app_type] => utility [patent_app_number] => 12/710382 [patent_app_country] => US [patent_app_date] => 2010-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 8111 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12710382 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/710382
Topical application of travoprost for combating hair loss Feb 22, 2010 Issued
Array ( [id] => 6590196 [patent_doc_number] => 20100130461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'Pharmaceutical composition for topical application' [patent_app_type] => utility [patent_app_number] => 12/657663 [patent_app_country] => US [patent_app_date] => 2010-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2604 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130461.pdf [firstpage_image] =>[orig_patent_app_number] => 12657663 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/657663
Pharmaceutical composition for topical application Jan 25, 2010 Abandoned
Array ( [id] => 6638605 [patent_doc_number] => 20100173956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'Use of Quaternary Pyridinium Salts as Vasoprotective Agents' [patent_app_type] => utility [patent_app_number] => 12/685377 [patent_app_country] => US [patent_app_date] => 2010-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4143 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173956.pdf [firstpage_image] =>[orig_patent_app_number] => 12685377 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/685377
Use of quaternary pyridinium salts as vasoprotective agents Jan 10, 2010 Issued
Array ( [id] => 6307714 [patent_doc_number] => 20100069498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'USE OF ALPHA-KETOGLUTARIC ACID FOR THE TREATMENT OF HIGH PLASMA GLUCOSE CONDITION' [patent_app_type] => utility [patent_app_number] => 12/626549 [patent_app_country] => US [patent_app_date] => 2009-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11108 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20100069498.pdf [firstpage_image] =>[orig_patent_app_number] => 12626549 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/626549
USE OF ALPHA-KETOGLUTARIC ACID FOR THE TREATMENT OF HIGH PLASMA GLUCOSE CONDITION Nov 24, 2009 Abandoned
Menu